Crossmark

The radiomics-based tumor heterogeneity adds incremental value to the existing prognostic models for predicting outcome in localized clear cell renal cell carcinoma: a multicenter study

Crossref DOI link: https://doi.org/10.1007/s00259-022-05773-1

Published Online: 2022-03-28

Published Print: 2022-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yang, Guangjie

Nie, Pei

Yan, Lei

Zhang, Mingxin

Wang, Yangyang

Zhao, Lianzi

Li, Mingyao

Xie, Fei

Xie, Haizhu

Li, Xianjun

Xiang, Fawei

Wang, Nan

Cheng, Nan

Zhao, Xia

Wang, Ning

Wang, Yicong

Chen, Chengcheng

Yun, Canhua

Cui, Jingjing

Duan, Shaofeng

Zhang, Ran

Hao, Dapeng

Wang, Ximing

Wang, Zhenguang https://orcid.org/0000-0003-1365-1198
Niu, Haitao
Funding

Funding for this research was provided by:

Postdoctoral Science Foundation of China (2018M642617)

Postdoctoral Science Foundation of China (2021M701811)
License Information

Text and Data Mining valid from 2022-03-28

Version of Record valid from 2022-03-28
More Information

Article History

Received: 12 November 2021

Accepted: 19 March 2022

First Online: 28 March 2022

Declarations

:

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee of the Affiliated Hospital of Qingdao University (Approval No. QYFY WZLL 25716) and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The informed consent was waived for this retrospective study.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below